KAZALD1

gene product
FKSG28, FKSG40
This gene encodes a secreted member of the insulin growth factor-binding protein (IGFBP) superfamily. The protein contains an insulin growth factor-binding domain in its N-terminal region, a Kazal-type serine protease inhibitor and follistatin-like domain in its central region, and an immunoglobulin-like domain in its C-terminal region. Studies of the mouse ortholog suggest that this protein may function in bone development and bone regeneration. This gene is hypomethylated and over-expressed in high-grade glioma compared to low-grade glioma, and thus the hypomethylated gene may be associated with cell proliferation and the shorter survival of patients with high-grade glioma. It is also one of numerous genes found to be deleted in a novel 5.54 Mb interstitial deletion, which is associated with multiple congenital anomalies. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
57 antibodies from 16 providers.

Antibody properties

General

Applications

or Cancel
Antibody
NovoPro Bioscience Inc.
1 antibody
antibodies-online
8 antibodies
Proteintech Group
1 antibody
LifeSpan BioSciences, Inc.
19 antibodies
Novus Biologicals
5 antibodies
Biorbyt
5 antibodies
Abnova Corporation
3 antibodies
Invitrogen Antibodies
3 antibodies
R&D Systems
3 antibodies
Atlas Antibodies
1 antibody
MyBioSource
1 antibody
Aviva Systems Biology
1 antibody
Boster Biological Technology
1 antibody
Creative Diagnostics
2 antibodies
Sigma-Aldrich
1 antibody
United States Biological
2 antibodies